1. Home
  2. VIAV vs FTRE Comparison

VIAV vs FTRE Comparison

Compare VIAV & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIAV
  • FTRE
  • Stock Information
  • Founded
  • VIAV 1923
  • FTRE 1996
  • Country
  • VIAV United States
  • FTRE United States
  • Employees
  • VIAV N/A
  • FTRE N/A
  • Industry
  • VIAV Semiconductors
  • FTRE Medical Specialities
  • Sector
  • VIAV Technology
  • FTRE Health Care
  • Exchange
  • VIAV Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • VIAV 2.2B
  • FTRE 1.9B
  • IPO Year
  • VIAV 1993
  • FTRE N/A
  • Fundamental
  • Price
  • VIAV $10.20
  • FTRE $19.26
  • Analyst Decision
  • VIAV Hold
  • FTRE Hold
  • Analyst Count
  • VIAV 9
  • FTRE 11
  • Target Price
  • VIAV $11.16
  • FTRE $23.30
  • AVG Volume (30 Days)
  • VIAV 1.7M
  • FTRE 1.3M
  • Earning Date
  • VIAV 01-30-2025
  • FTRE 11-08-2024
  • Dividend Yield
  • VIAV N/A
  • FTRE N/A
  • EPS Growth
  • VIAV N/A
  • FTRE N/A
  • EPS
  • VIAV N/A
  • FTRE N/A
  • Revenue
  • VIAV $990,700,000.00
  • FTRE $2,975,600,000.00
  • Revenue This Year
  • VIAV $4.76
  • FTRE N/A
  • Revenue Next Year
  • VIAV $6.97
  • FTRE $1.16
  • P/E Ratio
  • VIAV N/A
  • FTRE N/A
  • Revenue Growth
  • VIAV N/A
  • FTRE 2.80
  • 52 Week Low
  • VIAV $6.60
  • FTRE $16.53
  • 52 Week High
  • VIAV $11.49
  • FTRE $41.02
  • Technical
  • Relative Strength Index (RSI)
  • VIAV 48.12
  • FTRE 45.44
  • Support Level
  • VIAV $10.03
  • FTRE $17.82
  • Resistance Level
  • VIAV $11.49
  • FTRE $20.86
  • Average True Range (ATR)
  • VIAV 0.39
  • FTRE 1.55
  • MACD
  • VIAV -0.07
  • FTRE -0.37
  • Stochastic Oscillator
  • VIAV 12.84
  • FTRE 19.92

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: